EU CLOSE TO WRAPPING UP PRELIMINARY TALKS WITH U.S. FIRM NOVAVAX FOR THE SUPPLY OF POTENTIAL COVID-19 VACCINE - EU SOURCE
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.79 USD | +13.68% | +12.81% | +208.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+208.12% | 1.83B | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Eu Close To Wrapping Up Preliminary Talks With U.s. Firm Novavax For The Supply Of Potential Covid-19 Vaccine - Eu Source